Article
27 Feb 2026
Delaware Chancery Court Enforces Properly Limited Non-Compete While Delaware Supreme Court Affirms Refusal To Enforce Or "Blue Pencil" Overbroad Non-Competes
CONTRIBUTING SINCE MARCH 2011
Bass, Berry & Sims
Bass, Berry & Sims is a national law firm with nearly 350 attorneys dedicated to delivering exceptional service to numerous publicly traded companies and Fortune 500 businesses in significant litigation and investigations, complex business transactions, and international regulatory matters. For more than 100 years, our people have served as true partners to clients, working seamlessly across substantive practice disciplines, industries and geographies to deliver highly-effective legal advice and innovative, business-focused solutions. For more information, visit www.bassberry.com.
POPULAR TOPICS
Food, Drugs, Healthcare, Life Sciences
Government, Public Sector
Employment and HR
Corporate/Commercial Law
Privacy
Bass, Berry & Sims are most popular:
- with readers working within the Healthcare industries
DETAILS
United States
+1 615 742-6200
150 Third Avenue South Suite 2800
Nashville
United States
Contact Firm
COMPANY CONTENT
Article
26 Feb 2026
GAO: Conversion Did Not Void Procurement Eligibility
Article
26 Feb 2026
Export Enforcement Update: Huge Penalty Imposed For Semiconductor Re-Exports To China
Article
26 Feb 2026
California Enacts "Mini-HSR" Law, Joining Washington And Colorado
Article
23 Feb 2026
OFAC Enforcement Update: $1.72M Settlement Highlights Screening Gaps In Education, Similar Sectors
Article
23 Feb 2026
Best Practices For Responding To Government Investigations
Article
19 Feb 2026
14th Annual Healthcare Fraud & Abuse Review
Article
16 Feb 2026
Bid Protest Minute: GAO Rejects "Should Have Received More Strengths" Protest In $64M Army Task Order Competition
Article
16 Feb 2026
Bid Protest Minute: Pricing Narratives Won't Save You If Rates Look Unrealistic, GAO Says
Article
13 Feb 2026
Export Enforcement Update: EAR99 "In-Country" Transfers Lead To Penalty
Article
12 Feb 2026
OIG Issues New Guidance On DTC Drug Sales And AKS Risk
Article
12 Feb 2026
From 1999 To Prime Time: OIG Revamps Medicare Advantage Guidance For Today's—and Tomorrow's—Evolving Market
Article
11 Feb 2026
A Band-Aid On PAMA: Appropriation Bill Delays Cuts & Reporting Period; Updates Data
Article
09 Feb 2026
Congress Enacts New Attestation And Identifier Requirements For Off-Campus Hospital Outpatient Departments
Article
04 Feb 2026
Preventative Care Test Garners Commercial Cost-Sharing Waiver Flexibility From OIG
Article
30 Jan 2026
EEOC Rescinds 2024 Guidance On Harassment In The Workplace
Article
30 Jan 2026
SBA Suspends Over 1,000 8(a) Participants After Program-Wide Audit Data Request While DoW Announces Line-By-Line Review Of All Small Business Awards Over $20 Million
Article
28 Jan 2026
President Trump's NLRB Gains Quorum And GC, Flurry Of Activity Expected
Article
27 Jan 2026
Absent Congressional Action, Most Laboratories Required To Submit Outdated Data To CMS Beginning February 1, 2026
Article
27 Jan 2026
Reminder: Group Health Plans Should Update HIPAA Notice Of Privacy Practices By February 16
